Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001714899-22-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-02-11 | 2022-02-09 | DNLI | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $37.55 | -2,719 | 2.12M | -0.1% | -$102.1K |
| DM | 2022-02-11 | 2022-02-10 | DNLI | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $5.65 | +70.7K | 254.5K | +38% | +$400.0K |
| DM | 2022-02-11 | 2022-02-10 | DNLI | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.00 | -70.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | S | D | 2,719 | $37.55 | 2,119,442 | I See footnote | — | — | (F2) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $37.51 to $37.745 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person. (F4) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |
| 2 | Common | Common Stock | 2022-02-10 | M | A | 6,118 | $9.60 | 260,640 | D | — | — | (F5) Includes 189,891 restricted stock units. (F3) Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person. |
| 3 | Common | Common Stock | 2022-02-10 | M | A | 64,631 | $5.28 | 254,522 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2022-02-10 | M | D | 64,631 | $0.00 | 0 | D | $5.28 · — to 2027-03-07 | 64,631 Common Stock | (F6) The shares subject to the option were fully vested and exercisable. |
| 5 | Derivative | Stock Option (right to buy) | 2022-02-10 | M | D | 6,118 | $0.00 | 0 | D | $9.60 · — to 2027-08-21 | 6,118 Common Stock | (F6) The shares subject to the option were fully vested and exercisable. |